Markets:

Overview

News

Currencies

International

Treasuries

Pfizer (NY:PFE)

25.19 +0.15 (+0.60%)

Official Closing Price Updated: 7:00 PM EST, Dec 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

99 100 Next >

Eli Lilly Makes A Bold Claim For Its Biggest Cancer Drug ↗

October 17, 2025

Eli Lilly said Friday a combo using Verzenio cut the risk of death by nearly 16% over two years for breast cancer patients.

Via Investor's Business Daily

ASSET PLANNING Exits Full Stake in Pfizer Worth $2.7 Million ↗

October 16, 2025

Via The Motley Fool

Topics Regulatory Compliance

AI: The Medical Maverick – Navigating Hype and Hope in Healthcare’s Digital Revolution

October 16, 2025

Artificial intelligence (AI) stands at the precipice of a profound transformation in healthcare, promising a future where diagnostics are sharper, treatments are more personalized, and patient care is...

Via TokenRing AI

Topics Artificial Intelligence

QSM Asset Management Takes $11.5 Million Stake in Rio Tinto, Expands Energy Exposure ↗

October 16, 2025

Via The Motley Fool

Pfizer CEO Urges US-China Collaboration In Pharma; Stock Drops For 7th Day As Traders Hold For Dividend Payout ↗

October 14, 2025

Via Stocktwits

Navigating the Currents: Volatility and Growth Define U.S. Markets Amidst AI Boom and Geopolitical Headwinds

October 16, 2025

As of October 16, 2025, the U.S. stock market is a tapestry woven with threads of robust corporate earnings, groundbreaking technological advancements, and persistent geopolitical and economic...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

QSM Asset Management Buys $6.8 Million of Pfizer Stock as Pharma Giant Lags Market ↗

October 16, 2025

Via The Motley Fool

A Once-in-a-Decade Investment Opportunity: 1 Pharmaceutical Stock to Buy Now Hand Over Fist and Hold for Years ↗

October 16, 2025

It's the best time in a while to scoop up shares of this stock from the discount bin.

Via The Motley Fool

Topics Intellectual Property World Trade

Why Moderna Might Be a One-Hit Wonder ↗

October 15, 2025

Moderna's sales have plummeted in recent years along with diminishing demand for COVID vaccines.

Via The Motley Fool

Dividend Duo Delights Investors: Meta Platforms and Johnson & Johnson Shine in 2025

October 15, 2025

In a year marked by evolving market dynamics and a persistent search for both growth and stability, two distinct titans of industry—Meta Platforms (NASDAQ: META) and Johnson & Johnson (NYSE: JNJ)—have...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Curious about the most active S&P500 stocks in today's session? ↗

October 15, 2025

Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Wednesday and uncover the stocks that are leading the way in terms of trading volume and market...

Via Chartmill

Wall Street's Earnings Momentum Fades, Market Dips Amidst Trade Tensions

October 15, 2025

Wall Street witnessed a significant shift this Wednesday as an eagerly anticipated earnings push ultimately petered out, sending stocks into the red. This downturn followed a volatile Tuesday, which...

Via MarketMinute

Topics Economy Supply Chain World Trade

Pfizer CEO Reportedly Says Vaccine Approvals Getting Harder ↗

October 15, 2025

According to a report from Bloomberg, Bourla said that it's harder to get vaccine approvals and not drug approvals.

Via Stocktwits

Topics Government World Trade

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks With Over 3% Dividend Yields ↗

October 15, 2025

Via Benzinga

1 Safe-and-Steady Stock Worth Your Attention and 2 We Question

October 15, 2025

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Via StockStory

AI Revolutionizes Quality Control: A New Era of Precision and Speed in Manufacturing, Electronics, and Pharmaceuticals

October 14, 2025

A groundbreaking wave of Artificial Intelligence (AI) tools is poised to fundamentally transform materials quality checking, ushering in an era of unparalleled precision, speed, and cost-efficiency...

Via MarketMinute

Topics Artificial Intelligence Economy Fraud

Government Shutdown Casts Long Shadow Over Economy and Interest Rate Outlook Ahead of Powell's Pivotal Speech

October 14, 2025

The United States government is currently in the throes of its third week of a shutdown, a fiscal impasse that commenced on October 1, 2025, following a congressional failure to enact appropriations...

Via MarketMinute

Topics Economy Government Regulatory Compliance

These S&P500 stocks are the most active in today's session ↗

October 14, 2025

Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Tuesday. Discover the stocks that are generating the highest...

Via Chartmill

Pfizer Seeks Expanded Use Approval For Breast Cancer Drug ↗

October 14, 2025

Pfizer's Tukysa improved progression-free survival in first-line HER2+ metastatic breast cancer, showing strong efficacy and a manageable safety profile.

Via Benzinga

Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential ↗

October 14, 2025

Shah Capital urges Novavax to consider a sale after poor COVID-19 vaccine rollout, highlighting the potential value of at least $5 billion.

Via Benzinga

TUKYSA Combination Significantly Improves Progression-Free Survival as First-Line Maintenance in HER2+ Metastatic Breast Cancer in HER2CLIMB-05 Trial

October 14, 2025

From Pfizer Inc.

Via Business Wire

David Gardner: 9 Foolish Truths I Hold to Be Self-Evident ↗

October 14, 2025

Whether you're well steeped in Foolishness or at the beginning stages of your investing journey, these are nine foundational truths not to be forgotten.

Via The Motley Fool

1 Profitable Stock for Long-Term Investors and 2 Facing Headwinds

October 14, 2025

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Via StockStory

Why BrightSpring Health Services (BTSG) Stock Is Trading Up Today

October 13, 2025

Shares of healthcare services provider BrightSpring Health Services (NASDAQ:BTSG) jumped 3.3% in the afternoon session after several analysts signaled increased confidence in the company, with UBS...

Via StockStory

Topics Government Initial Public Offering

What's going on in today's session: S&P500 most active stocks ↗

October 13, 2025

Explore the S&P500 index on Monday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest.

Via Chartmill

Down 44%, Should You Buy the Dip on Viking Therapeutics? ↗

October 13, 2025

The company is readying to take on pharma giants Novo Nordisk and Eli Lilly.

Via The Motley Fool

Where Will Pfizer Be in 5 Years? ↗

October 13, 2025

Pfizer is working hard to deal with some big headwinds it has coming up, but in five years, this should all be in the past.

Via The Motley Fool

Topics Intellectual Property World Trade

Pfizer to Highlight Advancements in Respiratory Health and Infectious Disease Research at IDWeek 2025

October 13, 2025

From Pfizer Inc.

Via Business Wire

Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest? ↗

October 13, 2025

Now may be the time to invest in drug companies, as they just slipped the tariff noose.

Via The Motley Fool

Topics ETFs Government World Trade

4 Dividend Stocks to Double Up on Right Now -- Including United Parcel Service and Pfizer ↗

October 12, 2025

These great dividend stocks merit more attention from income investors.

Via The Motley Fool

Topics Economy Energy Government

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Pfizer (NY:PFE)

All News about Pfizer

Starting at $3.75/week.

Subscribe Today